Detecting the SLN by using methylene blue in patients affected by cervical cancer in the primitive stages; who were treated by surgical approaches in gynaecology wards in Baghiatallah Azam and Imam Khomeini hospitals

Detecting the SLN by using methylene blue in the primitive stages of cervical cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201205069656N1

Enrollment

Registered

2012-06-12

Start date

2012-06-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radical hysterectomy and lymphadenectomy/Cervical cancer.

Interventions

Dye injection into the SLN.

Early detection

Dye injection into the SLN

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: The patients affected by cervical cancer (Ib1-IIa stage) who are candidate for radical hysterectomy and lymphadenectomy will enter in this study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Biopsy/pathology result. Timepoint: 10 days. Method of measurement: Biopsy/Microscope.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Soheila Aminimoghaddam

Gynecology ward , Firoozgar Hospital, Tehran University of Medical Sciences

dr_aminimoghaddam@yahoo.com sh.daneshvar1984@gmail.com+98 21 2221 1688

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026